The lateral hypothalamus/perifornical area (LH/PFA) is a central chemoreceptor site, which acts in an arousal state-dependent manner. It has been shown that purinergic signalling through ATP influences the CO 2 /H + responsiveness of other chemosensitive regions, but it is unknown whether ATP is also involved in the mechanisms that underlie LH/PFA chemoreception. Here, we studied the effects of microdialysis of a P2X-receptor agonist [ , -methylene ATP ( , -meATP), 10 mM] and a non-selective P2-receptor antagonist [pyridoxal-phosphate-6-azophenyl-2 ′ ,4 ′ -disulfonate (PPADS), 1 mM] into the LH/PFA of conscious rats on ventilation in room air and in 7% CO 2 . In the dark (active) phase, but not in the light, microdialysis of , -meATP caused an augmented hypercapnic ventilatory response during wakefulness, but not during non-REM sleep (P < 0.001). PPADS caused no change in CO 2 ventilatory responses in either the dark period or the light period. Our data suggest that ATP in LH/PFA contributes to the hypercapnic ventilatory response in conscious rats during wakefulness in the dark phase of the diurnal cycle.
INTRODUCTION
Central chemoreception is the homeostatic process by which the brain detects variations in tissue pCO 2 /pH and activates suitable respiratory adjustments in order to maintain the acid-base balance. Central respiratory chemoreceptors are widely distributed throughout the brain, and evidence indicates that putative central chemoreceptor sites include the retrotrapezoid nucleus (RTN), the medullary raphe, the nucleus tractus solitarii (NTS), the fastigial nucleus of the cerebellum, the pre-Bötzinger complex, the locus coeruleus (LC), the caudal ventrolateral medulla (cVLM) and, more recently, the region including the lateral hypothalamus/perifornical area (LH/PFA) (Biancardi, Bícego, Almeida, & Gargaglioni, 2008; da Silva, Li, & Nattie, 2010; Dean, Lawing, & Millhorn, 1989; Guyenet, Stornetta, & Bayliss, 2008; Krause et al., 2009; Li, Li, & Nattie, 2013; Li, Randall, & Nattie, 1999; Nattie, 1999; Noronha-de-Souza et al., 2006; Taylor et al. 2006; Wang & Richerson, 1999) .
Orexins/hypocretins, neuropeptides encoded by neuronal cell bodies located exclusively in the LH/PFA (de Lecea et al., 1998; Sakurai c 2018 The Authors. Experimental Physiology c 2018 The Physiological Society the dark period, but not in the light period (Dias, Li, & Nattie, 2009) , strongly suggesting that the role of the LH/PFA in central chemoreception varies not only with arousal state, but also with the diurnal cycle.
Orexin-containing neurons are involved in a large range of physiological functions, one of these being sleep/wake regulation. For instance, it has been shown that orexin neurons are essential to promote and consolidate wakefulness (Carter, Borg, & de Lecea, 2009 ).
In addition, there is a diurnal variation of orexin concentrations in rat cerebrospinal fluid, with higher values during the dark period compared with the light period (Desarnaud et al., 2004) . Thus, the diurnal variation of the central chemoreception of the LH/PFA is congruent with the circadian-related activities of orexin.
It is well known that neuromodulators/neurotransmitters released by neurons and glia cells can influence orexinergic neuron activity.
For instance, ATP, an important intracellular energy source, is also involved in intercellular signalling (Burnstock, Campbell, Satchell, & Smythe, 1970) and influences orexinergic neuron depolarization (Wollmann, Acuna-Goycolea, & van den Pol, 2005) . ATP and its metabolite, adenosine, are known as extracellular purines, and they exert their diverse biological effects by acting on the so-called purinergic receptors. ATP activates P2 purinergic receptors, which are divided into P2X (ionotropic) and P2Y (G-coupled) classes (Burnstock, 1997; Fredholm et al., 1994; Ralevic & Burnstock, 1998) . It has been demonstrated that ATP contributes to the CO 2 /H + sensitivity of some chemosensitive sites, such as the RTN, ventrolateral medulla (VLM), LC and medullary raphe (Biancardi et al., 2008; Gourine et al., 2010; Huckstepp et al. 2010; Thomas, Ralevic, Gadd, & Spyer, 1999; Wang & Richerson, 1999) . Previous studies showed that CO 2 /H + causes ATP release from some chemosensitive regions located on the ventral surface of the medulla, including the RTN (Gourine, Llaudet, Dale, & Spyer, 2005; Kasymov et al., 2013) . In addition, the application of ATP in the RTN stimulated breathing, whereas the blockade of ATP receptors in this same region inhibited the hypercapnic ventilatory response (Gourine et al., 2005) . In the LC, injection of an ATP P2X-receptor agonist augmented the hypercapnic ventilatory response of conscious rats (Biancardi, Bícego, & Gargaglioni, 2014) , whereas injection of a P2-receptor blocker into the rostral medullary raphe inhibited the CO 2 ventilatory response (da Silva, Moraes, Giusti, Dias, & Glass, 2012) . Although the involvement of ATP in the CO 2 /H + -dependent drive to breathe has been well demonstrated, it remains to be determined whether ATP, acting specifically on the LH/PFA, contributes to the hypercapnic ventilatory response. In this regard, there is evidence for P2X and P2Y receptor expression in the LH/PFA (Xiang, Bo, Oglesby, Ford, & Burnstock, 1998) and, more specifically, it has been shown that orexin/hypocretin neurons express P2X 2 R and P2Y 4 R subunits (Florenzano et al., 2006; Song et al., 2011) .
Thus, we investigated the participation of purinergic neurotransmission, through ATP, on the LH/PFA in the hypercapnic ventilatory responses in conscious rats during the dark and light periods of the diurnal cycle. Our hypothesis is that purinergic signalling, in the LH/PFA, contributes to the central hypercapnic chemoreflex in a vigilance state-dependent manner.
New Findings

• What is the central question of this study?
ATP is known to modulate the chemosensitivity of some brain areas. However, whether the ATP contributes specifically to the mechanism of chemoreception in the lateral hypothalamus/perifornical area (LH/PFA) remains to be determined.
• What is the main finding and its importance? ATP, acting on the LH/PFA, enhances the hypercapnic ventilatory response in rats during wakefulness, in the dark period. Our results highlight the importance of ATP as a modulator of central chemoreception and provide new insight regarding the mechanisms involved in LH/PFA chemosensitivity and the sleep-wake differences in the CO 2 /H + -dependent drive to breathe.
METHODS
Ethical approval
All procedures were carried out in accordance with the guidelines of the National Council for the Control of Animal Experimentation (CONCEA, MCT, Brazil), with the approval of the Animal Care and Use Committee for the Institute of Biosciences at Botucatu, Brazil (CEUA -IBB, UNESP, Botucatu campus; protocol no. 597) and according to the principles and regulations on animal experimentation defined in the editorial by Grundy (2015) .
Animals
Male Wistar rats (250-320 g) were obtained from the Central Animal Facility of UNESP -Botucatu and were kept in a light-and temperature-controlled room (23 ± 2 • C), with free access to food and water, under a 12 h-12 h light-dark cycle (lights on at 14.00 h for the dark period group and at 07.00 h for the light period group). The experiments were performed between 09.00 and 13.00 h. For the dark period group, the animals were acclimated to a partly reversed lightdark cycle during 2 weeks before the experiment.
Surgery
Animals were submitted to general anaesthesia by intramuscular administration of ketamine (100 mg kg −1 ; Ceva, Paulínia, SP, Brazil) and xylazine (15 mg kg −1 ; Ceva). The head and a portion of the abdomen were shaved, and the skin was sterilized with betadine solution and alcohol. The rats were fixed in a Kopf stereotaxic frame and implanted with a dialysis guide cannula (CMA11; Microdialysis AB, Stockholm, Sweden) 1 mm above the LH/PFA region. The coordinates for the cannula placement were ∼3.3 mm caudal and 1.8 mm lateral to lambda, and 8.5 mm below the surface of the skull (Paxinos & Watson, 1998) .
For EEG recordings, three stainless-steel electrodes were screwed into the skull to provide recordings from the rat cortical surface. The EEG electrodes were positioned as follows: (i) in the right frontal cortex, 2 mm anterior to bregma and 2 mm lateral to the mid-line; (ii) in the right parietal cortex, 4 mm anterior to lambda and 2 mm lateral to the mid-line; and (iii) on the left side (the earth electrode), between the frontal and parietal electrodes. A pair of electrodes was inserted deep into the dorsal cervical neck muscle to record EMG, and the electrode wires were tunnelled under the skin until they reached the skull. A plastic pedestal was used as a socket for the placement for both EEG and EMG electrodes, and a dust cap was used on top to cover the electrode pedestal while it was not in use (Plastics One Inc., Roanoke, VA, USA). The electrodes and the guide cannula were mounted on and attached to the bone with acrylic cement. The wound was then sutured.
For body temperature (Tb) measurements, a temperature datalogger (SubCue Dataloggers, Calgary, Alberta, Canada) was implanted in the abdominal cavity through a mid-line laparotomy. The datalogger was programmed to take a reading every 5 min. At the end of surgery, rats received 0.2 ml (1,200,000 U) of benzyl penicillin (Zoetis, Campinas, SP, Brazil), administered I.M., and they were allowed to recover for 7 days.
Buprenorphine (0.05 mg kg −1 , S.C.; Schering-Plough, Kenilworth, NJ, USA) was administered 12 h later as a postoperative analgesic agent.
Microdialysis
In this study, we used microdialysis probes with an 11 mm stainlesssteel shaft and a 1-mm-long tip with a polyacrylonitrile membrane Harvard Apparatus, Holliston, MA, USA). , -Methylene ATP ( , -meATP; P2X-selective agonist; Sigma, St Louis, MO, USA; 10 mM) and pyridoxal-phosphate-6-azophenyl-2 ′ ,4 ′ -disulfonate (PPADS; P2 nonselective antagonist; Sigma; 1 mM) were dissolved in aCSF, and pH was adjusted to 7.4. The doses of the drugs were selected according to pilot experiments and previous studies (Biancardi et al., 2014; Sobrinho et al. 2014) .
Measurement of ventilation
Measurements of ventilation (V E ) were obtained by the whole-body plethysmograph method, as previously described (Bartlett & Tenney, 1970) . Briefly, freely moving rats were kept in a 5 litre chamber ventilated with room air or a hypercapnic gas mixture containing 7% CO 2 and 21% O 2 balanced with N 2 (White Martins, Sertãozinho, Brazil). The mixture of the gases was provided by a gas mixer (Pegas 4000F; Columbus Instruments, Columbus, OH, USA). The flow rate through the chamber was controlled by the gas mixer and maintained at 2 l min −1 to prevent CO 2 rebreathing. During measurements, the flow was interrupted, and the chamber was sealed for short periods of time (∼2 min). The pressure oscillations attributable to respiration were monitored by a differential pressure transducer (TSD 160A; Biopac Systems, Santa Barbara, CA, USA), passed through an analog-to-digital converter, and were digitized on a microcomputer equipped with data acquisition software (MP150WSW; Biopac Systems). Breathing events were analysed using the data analysis software, Lab Chart Pro (AD Instruments, Bella Vista, NSW, Australia). Tidal volume (V T ) was calculated using an appropriate formula (Malan, 1973) , andV E was calculated as the product of V T and respiratory frequency (f R ). The calibration for volume was obtained before each experiment by injecting 1 ml of room air into the chamber.
The temperatures in the room and inside the chamber were measured using a thermosensor (model HH801B; Spectris Brazil, Sao Paulo, SP, Brazil).
Determination of vigilance state
The EEG and EMG electrodes, inserted into the plastic pedestal, were connected to an insulated and shielded cable which, in turn, was attached to an electrical swivel to allow the rats to move freely inside the chamber. A four-channel amplifier was then connected to the opposite end of the swivel. The signals were amplified (×10,000 for EEG signals and ×2000 for EMG signals) and bandpass filtered (low and high cut-off: 10 and 500 Hz for EMG signals and 0.3 and 50 Hz for EEG signals, respectively). Signals were acquired (sample rate, 2 kHz) and recorded on a computer equipped with a Biopac acquisition system (MP150WSW; Biopac Systems). Arousal state was determined by analysis of EEG and EMG recordings, as previously described (Morrison et al., 2003) . Briefly, wakefulness was characterized by low frequencies and high neck muscle activity (for the active wakefulness) or low neck muscle activity (for the quiet wakefulness). Non-rapid eye movement (NREM) sleep presented high frequencies, high EEG amplitude and low activity of the neck muscle, whereas REM sleep showed low frequencies, high frequencies and low neck muscle activity.
Anatomical analysis
At the end of the experiments, the animals were deeply anaesthetized with pentobarbital (60 mg kg −1 , I.P.; Syntec, SP, Brazil) and perfused intracardially with 300 ml of phosphate buffer (PB), followed by 300 ml of 4% paraformaldehyde in 0.1 M PB, pH 7.4 at room temperature.
The perfusion was performed with the aid of a peristaltic perfusion pump (Masterflex; Cole Parmer International, Vernon Hills, IL, USA) adjusted to a flow of 30 ml min −1 . After the brain was removed, it was stored overnight in a 4% paraformaldehyde solution. The next day, the brain was cryoprotected by immersion in a 30% sucrose solution for ≥48 h. Then, the brain was frozen, sectioned at 40 m thickness with a Reichert-Jung cryostat (Leica, Germany) and stained by the Nissl method for light microscopy. The anatomical region of microdialysis was determined using the stereotaxic atlas of Paxinos and Watson (1998) . Only rats with the site of microdialysis in the LH/PFA were considered.
Statistical analysis
Values are reported as means ± SD. The variances in the ventilatory responses to hypercapnia among the groups were analysed by twoway ANOVA, followed by Bonferroni's test for post hoc comparisons.
For analysis of the percentage of time spent in wakefulness and NREM sleep during dark and light phases, a three-way repeatedmeasures ANOVA was applied. The significance level was set at P < 0.05. The statistical analysis was performed using a software program (GraphPad Prism5, GraphPad Software, La Jolla, CA, USA).
Experimental protocol
For all the experiments, the chamber temperature was maintained between 24 and 25 • C. Seven days after surgery, the rats were gently handled and the microdialysis probe was inserted into the guide cannula, followed by the connection of EEG and EMG electrode cables. The animals were then placed into a 5 litre plethysmograph chamber and allowed 40-60 min to acclimate. During this period, the chamber was flushed with room air and the animals were dialysed with aCSF without any measurement. After this acclimation period, the experimental recording began. In room-air conditions, ventilation, EEG, EMG and body temperature were recorded for 30 min during dialysis of aCSF. Respiratory and body temperature measurements were taken at 5 min intervals. The inspired air was then switched to a hypercapnic gas mixture, containing 7% CO 2 and 21% O 2 balanced with N 2 , and measurements were made for an additional 40 min. Subsequently, there was a period of rest for ≥1 h in room-air conditions, with the plethysmograph top opened and with dialysis of aCSF. The purpose of this period was to allow the rats to return to baseline conditions. The dialysate was then changed to the one with , -meATP or PPADS, and the protocol was repeated in the same rat. Respiratory Each rat received only one dialysis probe insertion and 1 day of experimentation. This protocol was performed in a group of rats during the light period and in another group during the dark period.
RESULTS
Anatomy
In Figure 1a , we show a representative stained section, indicating the probe placement in a single rat. The rats were divided into the following four groups: (i) microdialysis of , -meATP within the LH/PFA during the light phase (Figure 1b ; n = 6); (ii) microdialysis of , -meATP within the LH/PFA during the dark phase (Figure 1c ; n = 6); (iii) microdialysis of PPADS within the LH/PFA during the light phase (Figure 1d ; n = 5); and (iv) microdialysis of PPADS within the LH/PFA during the dark phase ( Figure 1e ; n = 6). A separate group with the probe tips located outside of the LH/PFA, measured during the dark phase, is not shown (n = 4). The percentage of time in wakefulness and NREM sleep in room air and 7% CO 2 before and after treatment during the light and dark period of the diurnal cycle are represented in Table 1 . Periods of REM sleep were not common in our experiments and, when they occurred, were very short. Therefore, periods during REM sleep, or when sleep state was indeterminate, were excluded from our analysis.
Vigilance states
The , -meATP or PPADS treatment did not significantly affect the percentage of wakefulness or NREM sleep in normocapnia or during hypercapnia. The percentage of time that the animals spent awake did not change between the dark and light phases. Carbon dioxide significantly increased the time the rats were awake in vehicle-and PPADS-treated rats during the light phase (P < 0.05).
3.3
The effects of microdialysis of , -meATP in the LH/PFA on the ventilatory response to hypercapnia during wakefulness and sleep in the light and dark periods
In Figure 3 , we show the effects of dialysis of 10 mM , -meATP into the LH/PFA on the hypercapnic ventilatory response during the dark period. As observed, the dialysis of , -meATP into the LH/PFA did not alter ventilation in normocapnic conditions but exacerbated the hypercapnic ventilatory response by 25% during wakefulness, compared with the control group (V E = 2315.80 ± 174.31 versus 1770.12 ± 325.41 ml kg −1 min −1 ; n = 6; P < 0.001). The effect was attributable to a significant increase in V T (P < 0.001). In contrast, , -meATP had no effect on the ventilatory response to 7% CO 2 during NREM sleep.
The effects of , -meATP microdialysis into the LH/PFA on ventilatory parameters during the light period are shown in Figure 4 .
We found that , -meATP did not alter the 'CO 2 response' compared with the microdialysis of vehicle, in either wakefulness (V E = 1903.42 ± 474.31 versus 1620.42 ± 387.62 ml kg −1 min −1 ; n = 6) or sleep (V E = 1369.88 ± 268.22 versus 1244.92 ± 97.50 ml kg −1 min −1 ; n = 4). 
The effects of microdialysis of PPADS in the
Body temperature
All groups responded to hypercapnia with a decrease in body Light phase Awake (%) 82.9 ± 18.2 94.3 ± 4.6 65.2 ± 34.3 82.3 ± 23.8 68.3 ± 18.9 93.2 ± 10.6* 60.5 ± 31.9 95.8 ± 4.3* NREM sleep (%) 17.1 ± 18.2 5.7 ± 4.6 34.8 ± 34.3 17.7 ± 23.8 31.7 ± 18.9 6.8 ± 10.6* 39.5 ± 31.9 4.2 ± 4.3* Percentage of time spent in wakefulness and NREM sleep in room air and 7% CO 2 during microdialysis of , -methylene ATP ( , -meATP), pyridoxalphosphate-6-azophenyl-2 ′ ,4 ′ -disulfonate (PPADS) and the vehicle solutions in the lateral hypothalamus/perifornical area, in the dark phase and light phase groups. Values are shown as means ± SD. *Significant difference (P < 0.05) between normocapnia and hypercapnia in the same group.
DISCUSSION
Despite evidence for the participation of purinergic neurotransmission in central chemosensitivity, its role in the LH/PFA in modulating the ventilatory response to hypercapnia had not been investigated previously. Our results demonstrate that ATP, acting on P2 receptors in the LH/PFA, stimulates the hypercapnic ventilatory response during wakefulness in the dark phase of the diurnal cycle in rats, because microdialysis of a stable ATP analogue in the LH/PFA exacerbated the ventilatory response to 7% CO 2 in awake rats during the dark, but not during the light period.
There is compelling evidence that purinergic neurotransmission influences central chemoreception. For example, it was shown in vivo that CO 2 /H + triggers ATP release from the ventral surface of the medulla (Gourine et al., 2005) , and ATP has been shown to increase the activity of respiratory chemoreceptors in the RTN (Mulkey, Mistry, Guyenet, & Bayliss, 2006) . Furthermore, a P2-receptor blocker injected into the RTN and into the medullary raphe decreased the ventilatory response to CO 2 in adult rats (da Silva et al., 2012; Wenker et al. 2012) , whereas the injection of a stable ATP analogue into the locus coeruleus increased the CO 2 ventilatory response (Biancardi et al., 2014) . The source of ATP seems to be the astrocytes, which appear to be CO 2 /pH sensitive (Gourine et al., 2010) . Changes in CO 2 /pH have been demonstrated to evoke ATP release from the astrocytes via opening of gap junction hemichannels (Huckstepp et al., 2010) . Upon release, ATP may contribute to chemoreception by increasing the excitability of chemosensitive neurons (Wenker, Sobrinho, Takakura, Moreira, & Mulkey, 2012) .
The mechanisms by which chemosensitive neurons respond to ATP, including details of the signalling pathways and receptor Awake Sleep F I G U R E 3 Hypercapnic ventilatory response is augmented by , -meATP in awake rats during the dark period. Effect of microdialysis of , -meATP (filled circles; n = 6) and vehicle solution (open circles; n = 6) into the lateral hypothalamus/perifornical area on tidal volume (V T ), respiratory frequency (f R ) and ventilation (V E ) of rats during wakefulness (left panels) or sleep (right panels) in room air or during exposure to 7% CO 2 in the dark period. *P < 0.01, , -meATP versus artificial cerebrospinal fluid subtypes involved, remain to be determined. The first suggestions, >15 years ago, had pointed out a possible role for P2X receptors in central chemoreception (Spyer & Thomas, 2000) . These receptors are ionotropics, subdivided into seven classes (P2X 1 -P2X 7 ) and are highly expressed throughout the brain, including the LH/PFA (Kanjhan et al., 1999; Xiang et al., 1998) . Among the P2X subunits, P2X 2 receptors have been found in chemosensitive regions (Kanjhan et al., 1999) , and ATP currents mediated by P2X 2 receptors are significantly potentiated with reductions in pH (King, Ziganshina, Pintor, & Burnstock, 1996) , whereas the currents through P2X 1 , P2X 3 and P2X 4 subunits are inhibited (Stoop, Surprenant, & North, 1997) . In contrast, the ventilatory response to hypercapnia was unchanged in P2X 2 knockout mice (Rong et al., 2003) . Nevertheless, differences in CO 2 ventilatory responses between the arousal states were not evaluated in that study.
Here, we asked whether ATP in the LH/PFA modulates the ventilatory response to CO 2 . We used the reverse microdialysis of a P2X-receptor agonist, , -meATP, into the LH/PFA of conscious rats. We used an in vivo approach in unanaesthetized rats specifically because this allowed us to examine and compare the ventilatory responses between different arousal states, particularly between wakefulness and NREM sleep. It is well known that the volume of inspired air is state dependent, being reduced during sleep and anaesthesia when compared with wakefulness (Nattie, 1999) .
Moreover, the role of each chemosensitive site seems to differ according to arousal state. In the case of LH/PFA, it was proposed to have a more predominant role in wakefulness (Li et al., 2013) .
As seen in the present study, the stable ATP analogue in the LH/PFA produced a robust increase in the hypercapnic ventilatory response during wakefulness, but not during sleep, in the dark period. Our results suggest that ATP, possibly acting via P2X purinoreceptors within the LH/PFA, exerts an excitatory effect on the hypercapnic chemoreflex in rats, but only in wakefulness during the dark phase of the diurnal cycle, which corresponds to the active phase in rodents.
The arousal state-dependent aspect of our findings allows us to suggest that purinergic signalling in the LH/PFA might increase the CO 2 sensitivity of this region owing to its action on orexinergic neurons, because it is well established that these neurons, located in the LH/PFA, highly express purinoreceptors, and besides, they are chemosensitive and modulate the hypercapnic ventilatory response in an arousal state-dependent manner (Li et al., 2013) . In fact, orexinergic neurons also have an important role in the maintenance of arousal (Gestreau, Bevengut, & Dutschmann, 2008) and exhibit higher activity during wakefulness (Lee, Hassani, & Jones, 2005; Li et al., 2013; Mileykovskiy, Kiyashchenko, & Siegel, 2005) . Moreover, it was demonstrated that the local acidification in LH/PFA increases the ventilation in rats during wakefulness, but not during NREM sleep (Li et al., 2013) .
Despite the importance of the orexin system on arousal, the effect of , -meATP on the hypercapnic ventilatory response, as seen in the present study, was not followed by an increased alertness of the rats. In the present study, we limited the exposure to normocapnia and hypercapnia to ∼30 min each. For protocols involving hypercapnia, this is a period of time that minimizes time-dependent brain pH regulatory processes but still allows the study of ventilatory responses in either wakefulness or NREM sleep. However, this protocol might not be totally adequate to evaluate the characteristics of wakefulness and NREM sleep fully. If this were the priority of our study, the trial period would have to be much longer. In fact, studies evaluating the time spent in wakefulness/sleep in rats during dark and light phases, usually involve EEG/EMG recordings for 24 h, i.e. 12 h light and 12 h dark period (Sanford, Yang, Liu, & Tang, 2006; Tang, Yang, & Sanford, 2007; Trachsel, Tobler, & Borbély, 1986) . In our study, during each 30 min recording we observed a tendency for the rats to spend more time awake during the dark/active period compared with the light/inactive phase. However, there was a great variability among the animals, with no significant difference between the light and dark groups. The fact is that we limited our recording period because priority was set on evaluating the hypercapnic chemoreflex, rather than evaluating vigilance states. This might explain the lack of effects on the arousal state during purinergic agonist and antagonist microdialysis and the lack of difference in the time spent in wakefulness between the dark and light phases. However, although the experimental period was short, we could see an arousal effect of CO 2 in the PPADS and its control group and a tendency of CO 2 to lessen sleep in the , -meATP and vehicle groups during the light period. Awake Sleep F I G U R E 5 PPADS has no effect on ventilatory parameters during the dark period. Effect of microdialysis of PPADS (filled circles; n = 6) and vehicle solution (open circles; n = 6) into the lateral hypothalamus/perifornical area on tidal volume (V T ), respiratory frequency (f R ) and ventilation (V E ) of rats during wakefulness (left panel) or sleep (right panel) in room air or during exposure to 7% CO 2 in the dark period
The effect of , -meATP was observed only during the dark/active period. We did not observe a significant difference between groups in the light/inactive period. However, we cannot totally exclude the possibility that ATP could also be acting during the light phase, because there was high variability in this group. Nevertheless, the light-dark cycle dependence of the role of ATP on the LH/PFA in the central chemoreflex, indicated in our study, is in accordance with the synchronized activity of orexin neurons with the light-dark period, which is higher in the dark/active phase of the diurnal cycle (Desarnaud et al., 2004) , and with the role of orexinergic neurons on central chemosensitivity, which is also predominant in the dark (Dias et al., 2010; . Thus, the lack of effect observed with the ATP analogue during the light phase might be attributable to the fact that the chemosensitive role of orexinergic neurons, which are the main candidates for the ATP signalling during hypercapnia, is predominant in the dark/active phase of the diurnal cycle.
Moreover, it has been demonstrated that ATP exhibits a circadian oscillation of its extracellular levels in the suprachiasmatic nucleus of rats, with its highest levels in the dark phase (Womac, Burkeen, Neuendorff, Earnest, & Zoran, 2009) , and there is a time-of-daydependent variation of the expression of purinergic receptors in the mouse suprachiasmatic nucleus circadian pacemaker, with the P2X 1 , P2X 3 and P2X 4 immunoreaction being significantly increased during the late dark period (Lommen, Stahr, Ingenwerth, Ali, & von Gall, 2017 ). Therefore, it is possible that the circadian variation in purinergic receptor expression, which has been shown in the suprachiasmatic nucleus, also occurs in other regions involved with biological rhythms, such as the LH/PFA, and this could explain our results.
There is some evidence that purinergic neurotransmission in the CNS is involved in thermoregulation (Gurin, Gurin, Melenchuk, & Spyer, 2003) . However, , -meATP in the LH/PFA had no effect on body temperature in the control conditions or during hypercapnia in all experimental groups. These results suggest that purinergic signalling in the LH/PFA does not influence body temperature regulation in our experimental conditions.
The results presented here build on the possibility, shown in (Dias et al., 2009 (Dias et al., , 2010 or respiratory neurons (Dutschmann, Kron, Morschel, & Gestreau, 2007; Peever, Lai, & Siegel, 2003; Young et al., 2005) as P CO 2 rises and extracellular pH diminishes, and the ATP signalling might enhance this respiratory output during wakefulness. The characteristics of the neural components, besides the purinergic system, interacting with the orexin system to provide the state-and circadian-dependent modulation of CO 2 sensitivity are still not fully understood, and it is crucial to elucidate the mechanisms, which may be involved in some pathophysiological conditions, including obstructive sleep apnoea. Indeed, orexin-deficient mice have an increase in sleep apnoea events (Nakamura, Zhang, Yanagisawa, Fukuda, & Kuwaki, 2006) and an attenuation of respiratory longiterm facilitation induced by intermittent hypoxia, which is an experimental model of repetitive sleep apnoea (Toyama, Sakurai, Tatsumi, & Kuwaki, 2009 ).
Based on the results described earlier, it is reasonable to expect that P2 antagonism would decrease the ventilatory response to hypercapnia. However, the microdialysis of PPADS had no significant effect on the hypercapnic ventilatory response in either wakefulness or sleep, during the dark or light period of the diurnal cycle. There are at least two possible reasons for this. First, non-specific inhibitory effects of PPADS, such as decreased glutamate signalling, ecto-ATPase activity and IP 3 -induced Ca 2+ release, among other effects, have been described in the literature (Lambrecht, 2000; Lorier et al., 2004; Motin & Bennett, 1995) . Second, it is possible that the concentration used in our study was not high enough to result in the maximal blockade of P2 receptors. Higher doses were tested but elicited a compulsive feeding behaviour, which disturbed the pulmonary ventilation recordings. A concentration of 1 mM was the highest concentration achieved that did not produce alterations in behaviour that affected breathing.
In summary, our data suggest that the ATP in the LH/PFA potentially acts as an excitatory modulator of the ventilatory response to hypercapnia in rats during wakefulness in the dark/active, but not in the light/inactive, period of the diurnal cycle. These findings provide new insight regarding the mechanisms involved in LH/PFA chemosensitivity and the sleep-wake differences in the CO 2 /H + -dependent drive to breathe.
Thus, we conclude that ATP might contribute to the mechanism of chemoreception of the LH/PFA in a state-and light-dark cycledependent manner. 
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